Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicone breast implants

This article was originally published in The Gray Sheet

Executive Summary

Little data exists on the use of silicone implants in breast cancer patients, according to a report sponsored by the National Research Center for Women & Families. "Sadly, those [breast cancer patients] are the women who, if products come on the market, will have been least studied and need to be studied the most," Susan Wood, PhD, former director of FDA's Office of Women's Health, said at a Feb. 3 press briefing in Washington, D.C. Silicone implants were made available for reconstruction in women with breast cancer under a Compassionate Need Exemption in 1992...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT023192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel